Comments
Loading...

DocGo Analyst Ratings

DCGONASDAQ
Logo brought to you by Benzinga Data
$2.25
-0.10-4.26%
At close: -
$2.25
0.000.00%
After Hours: 4:34 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$4.00
Consensus Price Target1
$6.25

DocGo Analyst Ratings and Price Targets | NASDAQ:DCGO | Benzinga

DocGo Inc has a consensus price target of $6.25 based on the ratings of 6 analysts. The high is $11 issued by Deutsche Bank on April 19, 2022. The low is $4 issued by Needham on April 8, 2025. The 3 most-recent analyst ratings were released by Needham, Stifel, and Needham on April 8, 2025, February 28, 2025, and February 28, 2025, respectively. With an average price target of $4.5 between Needham, Stifel, and Needham, there's an implied 100.00% upside for DocGo Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
2
Feb
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Stifel
Cantor Fitzgerald
BTIG
Canaccord Genuity

1calculated from analyst ratings

Analyst Ratings for DocGo

Buy NowGet Alert
04/08/2025Buy Now77.78%Needham
Ryan MacDonald56%
$4 → $4ReiteratesBuy → BuyGet Alert
02/28/2025Buy Now144.44%Stifel
David Grossman62%
$6.5 → $5.5MaintainsBuyGet Alert
02/28/2025Buy Now77.78%Needham
Ryan MacDonald56%
$7 → $4MaintainsBuyGet Alert
01/16/2025Buy Now211.11%Needham
Ryan MacDonald56%
$7 → $7ReiteratesBuy → BuyGet Alert
09/20/2024Buy Now122.22%Cantor Fitzgerald
Sarah James53%
$5 → $5ReiteratesOverweight → OverweightGet Alert
08/20/2024Buy Now122.22%Cantor Fitzgerald
Sarah James53%
$5 → $5ReiteratesOverweight → OverweightGet Alert
08/08/2024Buy Now211.11%Needham
Ryan MacDonald56%
$7 → $7ReiteratesBuy → BuyGet Alert
05/09/2024Buy Now211.11%BTIG
David Larsen43%
$11 → $7MaintainsBuyGet Alert
05/09/2024Buy Now122.22%Canaccord Genuity
Richard Close46%
$9 → $5MaintainsBuyGet Alert
05/09/2024Buy Now211.11%Needham
Ryan MacDonald56%
$10 → $7MaintainsBuyGet Alert
05/09/2024Buy Now122.22%Cantor Fitzgerald
Sarah James53%
$11 → $5MaintainsOverweightGet Alert
04/30/2024Buy Now188.89%Stifel
David Grossman62%
$8 → $6.5MaintainsBuyGet Alert
04/11/2024Buy Now300%Canaccord Genuity
Richard Close46%
$10 → $9MaintainsBuyGet Alert
04/10/2024Buy Now255.56%Stifel
David Grossman62%
$11 → $8MaintainsBuyGet Alert
04/10/2024Buy Now388.89%BTIG
David Larsen43%
$13 → $11MaintainsBuyGet Alert
02/29/2024Buy Now388.89%Cantor Fitzgerald
Sarah James53%
$13 → $11MaintainsOverweightGet Alert
02/29/2024Buy Now344.44%Canaccord Genuity
Richard Close46%
$11 → $10MaintainsBuyGet Alert
02/29/2024Buy Now344.44%Needham
Ryan MacDonald56%
$14 → $10MaintainsBuyGet Alert
02/23/2024Buy Now388.89%Stifel
David Grossman62%
$12 → $11MaintainsBuyGet Alert
11/27/2023Buy Now433.33%Stifel
David Grossman62%
→ $12ReiteratesBuy → BuyGet Alert
10/02/2023Buy Now477.78%Cantor Fitzgerald
Sarah James53%
→ $13ReiteratesOverweight → OverweightGet Alert
09/19/2023Buy Now477.78%BTIG
David Larsen43%
$15 → $13MaintainsBuyGet Alert
09/18/2023Buy Now433.33%Stifel
David Grossman62%
→ $12ReiteratesBuy → BuyGet Alert
09/18/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14ReiteratesBuy → BuyGet Alert
09/14/2023Buy Now477.78%Cantor Fitzgerald
Sarah James53%
→ $13ReiteratesOverweight → OverweightGet Alert
09/07/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14ReiteratesBuy → BuyGet Alert
08/23/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14ReiteratesBuy → BuyGet Alert
08/22/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14ReiteratesBuy → BuyGet Alert
08/18/2023Buy Now566.67%BTIG
David Larsen43%
→ $15Initiates → BuyGet Alert
08/08/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14ReiteratesBuy → BuyGet Alert
07/31/2023Buy Now433.33%Stifel
David Grossman62%
$12 → $12ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now433.33%Stifel
David Grossman62%
→ $12ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now477.78%Canaccord Genuity
Richard Close46%
→ $13ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14ReiteratesBuy → BuyGet Alert
04/21/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14Reiterates → BuyGet Alert
04/21/2023Buy Now388.89%Cantor Fitzgerald
Sarah James53%
→ $11Initiates → OverweightGet Alert
03/14/2023Buy Now522.22%Needham
Ryan MacDonald56%
→ $14Reiterates → BuyGet Alert
04/19/2022Buy Now388.89%Deutsche Bank
Pito Chickering67%
→ $11Initiates → BuyGet Alert

FAQ

Q

What is the target price for DocGo (DCGO) stock?

A

The latest price target for DocGo (NASDAQ:DCGO) was reported by Needham on April 8, 2025. The analyst firm set a price target for $4.00 expecting DCGO to rise to within 12 months (a possible 77.78% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for DocGo (DCGO)?

A

The latest analyst rating for DocGo (NASDAQ:DCGO) was provided by Needham, and DocGo reiterated their buy rating.

Q

When was the last upgrade for DocGo (DCGO)?

A

There is no last upgrade for DocGo

Q

When was the last downgrade for DocGo (DCGO)?

A

There is no last downgrade for DocGo.

Q

When is the next analyst rating going to be posted or updated for DocGo (DCGO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DocGo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DocGo was filed on April 8, 2025 so you should expect the next rating to be made available sometime around April 8, 2026.

Q

Is the Analyst Rating DocGo (DCGO) correct?

A

While ratings are subjective and will change, the latest DocGo (DCGO) rating was a reiterated with a price target of $4.00 to $4.00. The current price DocGo (DCGO) is trading at is $2.25, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch